Bank of Montreal
GTBP icon

Bank of Montreal’s GT Biopharma GTBP Stock Holding History

Bank of Montreal’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,834
Closed -$8.51K – 3858
2025
Q4 		$8.51K Sell
10,834
-81,696
-88% -$58K ﹤0.01% 3436
2025
Q3 		$54.6K Hold
92,530
– – ﹤0.01% 3097
2025
Q2 		$331K Buy
92,530
+77,879
+532% +$201K ﹤0.01% 2535
2025
Q1 		$32.8K Sell
14,651
-14,300
-49% -$33.6K ﹤0.01% 3139
2024
Q4 		$88.3K Sell
28,951
-921
-3% -$2.49K ﹤0.01% 2983
2024
Q3 		$63K Hold
29,872
– – ﹤0.01% 3364
2024
Q2 		$93.2K Buy
29,872
+10,000
+50% +$35.8K ﹤0.01% 3257
2024
Q1 		$102K Sell
19,872
-3
-0% -$16 ﹤0.01% 3280
2023
Q4 		$170K Hold
19,875
– – ﹤0.01% 3188
2023
Q3 		$167K Hold
19,875
– – ﹤0.01% 3129
2023
Q2 		$262K Buy
19,875
+4,662
+31% +$48.3K ﹤0.01% 3053
2023
Q1 		$320K Buy
+15,213
New +$349K ﹤0.01% 2745

Other funds holding GTBP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return

Bank of Montreal's GTBP Position: Q1 2026 in Review

Bank of Montreal sold out of GT Biopharma (GTBP) in Q1 2026, closing a stake of 10,834 shares — an estimated $8.51K sold.

Bank of Montreal first reported a position in GTBP in Q1 2023 and held it in 12 quarters. The position peaked at $331K in Q2 2025. 42 funds tracked by Wall St. Rank hold GTBP as of Q1 2026.

  • Bank of Montreal reported no remaining GT Biopharma position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 10,834 GT Biopharma shares in Q1 2026, an estimated $8.51K.
  • Bank of Montreal first reported a position in GT Biopharma in Q1 2023 and held it in 12 quarters.
  • Bank of Montreal's GT Biopharma position peaked at $331K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.